Full Text View
Tabular View
No Study Results Posted
Related Studies
Induction of Clinical Response Using Rifaximin in Crohn's Disease
This study is currently recruiting participants.
Study NCT00603616   Information provided by University of Washington
First Received: January 16, 2008   Last Updated: May 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Crohn's Disease
Additional conditions recognized in this trial
Crohn Disease
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Inflammatory Bowel Diseases
Intestinal Diseases
Interventions listed in this trial
Placebo Comparator
Rifaximin
More general drug interventions related to this trial
Anti-Infective Agents
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Washington
Salix Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services